In episode 81 we discuss using mirtazapine to treat methamphetamine
use disorder.
McKetin R, Shoptaw S, Saunders L, et al. Mirtazapine for Methamphetamine Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2026;83(6):581–589. doi:10.1001/jamapsychiatry.2026.0159
We also discuss behavioral treatments added to buprenorphine,
and how the FDA is promoting flavored nicotine products.
JAMA Network Open: Adjunctive Psychosocial Interventions and Opioid Abstinence Among Patients Receiving Buprenorphine
NBC News: Some ZYN nicotine pouches can be sold as safer than cigarettes, FDA says
---
This podcast offers category 1 and MATE-ACT CME credits through MI CARES and Michigan State University. To get credit for this episode
and others, go to this link to make your account, take a brief quiz, and claim your credit. To learn more about opportunities in addiction medicine, visit MI CARES.
CME: https://micaresed.org/courses/podcast-addiction-medicine-journal-club/
---
Original theme music: composed and performed by Benjamin Kennedy
Audio editing: Michael Bonanno
Executive producer: Dr. Patrick Beeman
A podcast from Ars Longa Media
---
This is Addiction Medicine Journal Club with Dr. Sonya Del Tredici and Dr. John Keenan. We practice addiction medicine and primary care, and we believe that addiction is a disease that can be treated. This podcast reviews current articles to help you stay up to date with research that you can use in your addiction medicine practice.
The best part of any journal club is the conversation. Send us your comments on social media or join our Facebook group.
---
Email: addictionmedicinejournalclub@gmail.com
Facebook: @AddictionMedJC
Facebook Group: Addiction Medicine Journal Club
Instagram: @AddictionMedJC
Threads: @AddictionMedJC
YouTube: addictionmedicinejournalclub
Twitter/X: @AddictionMedJC
---
Addiction Medicine Journal Club is intended for educational purposes only and should not be considered medical advice. The views expressed here are our own and do not necessarily reflect those of our employers or the authors of the articles we review. All patient information has been modified to protect their identities.
Learn more about your ad choices. Visit megaphone.fm/adchoices
